[Granulocyte colony-stimulating factors as a support therapy in malignant diseases].
Riikonen
Pekka
P
KYS:n lastentautien klinikka PL 1777, 70211 Kuopio.
Elonen
Erkki
E
Teerenhovi
Lasse
L
D000367:Age Factors; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects*; D001853:Bone Marrow / Q000187:drug effects*; D004359:Drug Therapy, Combination; D016179:Granulocyte Colony-Stimulating Factor / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D009503:Neutropenia / Q000139:chemically induced* / Q000517:prevention & control*; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome
D000964:Antimetabolites, Antineoplastic; D016179:Granulocyte Colony-Stimulating Factor